How to Buy

COMING 2021 - The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis.

Optimized to meet your infection prevention needs today and in the future, CaviWipes 2.0 is one of the surface disinfectants that fully qualifies for the EPA's rigorous Emerging Viral Pathogen Claim.

Features and Benefits

  • 2-Minute Universal Contact Time
  • Effective against 41 pathogens including Norovirus, Candida auris, and Novel Coronavirus (COVID-19)1
  • Compatible with non-porous, hard surfaces
  • Qualifies for the EPA's Emerging Viral Pathogens claim for all virus types (enveloped, large and small non-enveloped viruses)2
  • Easy-to-Use Label easy to find critical information on efficacy, compatibility, and more

 

CaviWipes 2.0 Kill Claims

2-Minute Efficacy Against3:

  • Mycobacterium Bacteria
  • Mycobacterium tuberculosis (TB)
  • Non-enveloped Viruses
  • Adenovirus Type 2
  • Echovirus Type 11
  • Enterovirus Type 71
  • Human Rotavirus
  • Norovirus
  • Pathogenic Fungi
  • Candida auris
  • Multi Drug-Resistant Bacteria
  • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
  • Vancomycin-Resistant Enterococcus faecalis (VRE)
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
  • Multidrug-Resistant Acinetobacter baumannii (MRAB)
  • NDM-1 Enterobacter cloacae
  • Vancomycin-Intermediate Staphylococcus aureus (VISA)
  • Bacteria
  • Acinetobacter baumannii
  • Bordetella pertussis
  • Burkholderia cepacia
  • Enterococcus faecium
  • Escherichia coli O157:H7
  • Klebsiella pneumoniae
  • Legionella pneumophila
  • Micrococcus luteus
  • Moraxella catarrhalis
  • Pseudomonas aeruginosa
  • Salmonella enterica
  • Staphylococcus aureus
  • Stenotrophomonas maltophilia
  • Streptococcus mutans
  • Streptococcus pyogenes
  • Enveloped Viruses
  • Herpes simplex virus Type 1
  • Herpes simplex virus Type 2
  • lnfluenza A virus
  • lnfluenza B virus
  • Parainfluenza virus Type 3
  • Human orthopneumovirus
  • SARS-associated Coronavirus
  • Measles virus
  • Hepatitis C Virus (HCV)
  • Hepatitis B Virus (HBV)
  • Human lmmunodeficiency Virus Type 1 (HIV-1)

1. Reference - List N: Disinfectants for Use Against SARS-CoV-2. https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2. Accessed 8/14.2020.To kill SARS-CoV-2 (COVID-19), please follow the disinfection instructions for each product in accordance with List N.

2.Refer to CaviWipes 2.0 Master Label at https://iaspub.epa.gov/apex/pesticides/f?p=PPLS:8:6469043000138::NO::P8_PUID,P8_RNUM:531054,46781-17

3. Always follow Product Label for Cleaning/Disinfection Directions

MKT-20-0753 

List of Uses

  • Hard non-porous surfaces of laboratory equipment and surfaces,
  • Toys (plastic or hard non-porous),
  • Operating room tables and lights,
  • Physical therapy (PT) equipment surfaces,
  • Patient support equipment,
  • Exterior surfaces of ultrasound machines,
  • Exterioir surfaces of dialysis machines,
  • Exterior surfaces of IV pumps,
  • External surfaces of glucometers,
  • Ambulance equipment surfaces,
  • Keyboards, desktops,
  • Other critical care areas where control of cross contamination between hard non-porous surfaces is important.

MSDS & Literature

Ordering Information

How to Order

SKU Description
14-1100

CaviWipes 2.0 (6" x 6.75"), 160 wipes per canister

14-1150

CaviWipes 2.0 XL (9" x 12"), 65 wipes per canister

Images & Videos: 

Images

Metrex_CaViWipes_2.0_SurfaceDisinfection_14-1100_CW_2.0_160_Canister_Front_Flat.png

CaviWipes™ 2.0 Front

Metrex_CaViWipes_2.0_SurfaceDisinfection_14-1100_CW_2.0_160_Canister_Rear_Flat.png

CaviWipes™ 2.0 Back

Circle of Care

CaviWipes 2.0 is recommended for surface disinfection in many critical touch points in the Circe of Care, including: Patient Rooms, Operating Rooms, Hallways, Mobile Equipment, Endoscopy, and Sterile Processing Department.

Learn More